Longaeva Partners’s Electra Therapeutics ETRA Stock Holding History
Bought
Maintained
Sold
Other funds holding ETRA
Longaeva Partners's ETRA Position: Q3 2026 in Review
Longaeva Partners opened a new position in Electra Therapeutics (ETRA) in Q3 2026: 25,000 shares worth $281K. The stake represents 0.01% of the portfolio and ranks #288 among its holdings.
59 funds tracked by Wall St. Rank hold ETRA as of Q3 2026.
- Longaeva Partners held 25,000 shares of Electra Therapeutics worth $281K as of Q3 2026.
- Electra Therapeutics was a new Longaeva Partners position in Q3 2026.
- Electra Therapeutics made up 0.01% of Longaeva Partners's portfolio in Q3 2026, its #288 holding.
- 59 funds tracked by Wall St. Rank held Electra Therapeutics as of Q3 2026.
Based on Longaeva Partners's 13F filing for Q3 2026, filed 16 Nov 2026.